Bargains! PROMOTIONS

Close Notification

Your cart does not contain any items

$318.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
23 January 2026
REVOLUTIONIZING DRUG DEVELOPMENT: HARNESSING AI AND

COMPUTATIONAL BIOLOGY
Edited by:  
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 276mm,  Width: 216mm, 
Weight:   450g
ISBN:   9780443340598
ISBN 10:   0443340595
Pages:   354
Publication Date:  
Audience:   College/higher education ,  Professional and scholarly ,  Primary ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
1. Artificial intelligence and accelerated computing in drug discovery: An updated overview 2. AI strategies for drug discovery and bioactivity prediction: Opportunities and challenges 3. AI technologies for revealing new targets for drug discovery: Current findings and future directions 4. AI technologies for drug repurposing: Methods and applications 5. AI-designed drugs: Clinical development and future directions 6. AI-driven synthesis of drug-like compounds: Edge methods and current findings 7. Data science and databases in drug discovery: Technical development and applications 8. AI-based software for drug discovery: Tools and applications 9. Graph neural networks for drug discovery: Protocols and applications 10. Deep learning and generative models for drug discovery: Techniques and current achievements 11. AI technologies in structure-based drug design: technological advancements and limitations 12. AI-assisted clinical trial design for drug development: Strategies and challenges 13. AI-enabled personalized medicine: Strategies and challenges 14. Integrating AI technologies with drug development programs: Strategies and challenges 15. AI technologies for advancing R&D in the pharmaceutical industry: Current development and challenges

Jen-Tsung Chen is a Professor of Cell Biology at the National University of Kaohsiung in Taiwan, where he teaches cell biology, genomics, proteomics, plant physiology, and plant biotechnology. His research spans bioactive compounds, chromatography techniques, plant molecular biology, bioinformatics, systems pharmacology, and broader themes in biotechnological plant disease management, plant biotic stress responses, nanotechnology for combating pests and pathogens, ethnopharmacology, and systems biology. An active scholar, Dr. Chen serves on the editorial boards of several international journals and has guest‑edited numerous special issues. He has also authored and edited books with major international publishers on topics including drug discovery, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, CRISPR‑based genome editing, and artificial intelligence. Recognized for his scientific impact and editorial leadership, Dr. Chen was listed among Elsevier and Stanford University’s “World’s Top 2% Scientists” in 2023 and 2024 and received the Springer Nature Editor of Distinction Award in 2025.

See Also